Sisomicin (CAS 32385-11-8)

Sisomicin, bearing the CAS number 32385-11-8, is an aminoglycoside antibiotic derived from the bacterium Micromonospora inyoensis. Structurally similar to other aminoglycosides, sisomicin works by binding to the bacterial 30S ribosomal subunit, a critical component in the protein synthesis machinery. This binding interferes with the initiation complex of mRNA and tRNA, leading to misreading of the mRNA template and subsequent incorporation of incorrect amino acids into polypeptides. The resultant proteins are often dysfunctional, leading to bacterial growth inhibition and cell death. The specificity of sisomicin′s interaction with the 30S ribosome makes it a valuable tool in molecular biology research for investigating ribosomal function and protein synthesis. Additionally, sisomicin has been utilized in studies aiming to understand the mechanisms of aminoglycoside action and resistance, particularly in genetic and enzymatic pathways that alter drug binding to ribosomes. Such research is vital for developing strategies to mitigate resistance and enhance the efficacy of similar compounds. Moreover, its role in inducing misreading of mRNA is exploited in studies related to translational fidelity, offering insights into the fundamental processes of genetic translation and its regulation within bacterial cells.